CCM
INSM icon

Consonance Capital Management’s Insmed INSM Stock Holding History

Consonance Capital Management’s Portfolio INSM Stock Details INSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-1,711,150
Closed -$43.8M – 32
2019
Q2 		$43.8M Buy
+1,711,150
New +$47.7M 3.1% 14

Other funds holding INSM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Consonance Capital Management's INSM Position: Q3 2019 in Review

Consonance Capital Management sold out of Insmed (INSM) in Q3 2019, closing a stake of 1,711,150 shares — an estimated $43.8M sold.

Consonance Capital Management first reported a position in INSM in Q2 2019 and held it in 1 quarter. The position peaked at $43.8M in Q2 2019. 157 funds tracked by Wall St. Rank hold INSM as of Q3 2019.

  • Consonance Capital Management reported no remaining Insmed position as of Q3 2019 after selling out during the quarter.
  • Consonance Capital Management sold 1,711,150 Insmed shares in Q3 2019, an estimated $43.8M.
  • Consonance Capital Management first reported a position in Insmed in Q2 2019 and held it in 1 quarter.
  • Consonance Capital Management's Insmed position peaked at $43.8M in Q2 2019.
  • 157 funds tracked by Wall St. Rank held Insmed as of Q3 2019.

Based on Consonance Capital Management's 13F filing for Q3 2019, filed 14 Nov 2019.